Stephanie Lewis: Unscripted

A new study reveals a significant financial confidence gap between military and civilian households, highlighting the impact of unique benefits and coaching.

Facing a severe cash crunch and delisting threats, the biotech firm is halting development and seeking buyers for its innovative cancer drug pipeline.

Investors eye Amerant Bancorp's Q1 results for signs of a turnaround after a challenging Q4 and a recent leadership change. Will its new strategy pay off?

In a key strategic move, Clear Channel Outdoor partners with Matter Communications to amplify its leadership in an OOH industry transformed by AI and data.

Two homegrown firms are building AI-powered hubs for at-home care, aiming to support Canada's strained system and aging population before it's too late.

A high-tech tour and hands-on engineering give local students a glimpse into their future, as one company invests in diversifying the industrial workforce.

Aurinia Pharmaceuticals' deal for Kezar Life Sciences hinges on zetomipzomib, a promising but risky drug poised to tackle a rare autoimmune liver disease.

A shareholder proposal targeting GE's sales to Israel sparks a clash between human rights advocates and groups decrying it as a discriminatory BDS tactic.

A new protocol aims to tokenize AI hardware, bridging a $2.5T finance gap and creating a new asset class for the digital age. Here's how it works.

Top execs from Hyundai, dealer associations, and policy groups will debate the future of EVs, trade, and affordability at a critical new NYIAS panel.

For the third straight year, a Texas dealership is the world's top Chevy seller. Discover the blend of community focus and business mastery behind their dynasty.

Trooly.AI's new platform uses AI agents to conduct 45-minute user interviews, but its 'Empathy Engine' raises new questions about tech and ethics.

An activist investor and top proxy advisor ISS are urging ProCap Financial shareholders to reject a controversial AI merger, citing conflicts and dilution.

Beyond the hype, enterprise leaders gather in Toronto to build the future of AI with composable architecture, promising measurable results and agentic ecosystems.

PetaSight's acquisition of Babbage Insight aims to fix a broken system with an 'intelligent OS', tackling the 38% data discard rate in life sciences PMR.

Industrial giant Rockwell Automation is set to demonstrate how AI, digital twins, and secure OT are moving factories from simple automation to full autonomy.

A new 750-patient clinical trial is underway to provide definitive evidence for advanced thrombectomy, potentially changing how deadly blood clots are treated.

A new initiative connects ranchers and schools, aiming to bring local beef to lunch trays while navigating economic and environmental complexities.

Helios & Partners invests in a free AI tool, signaling a major shift from SEO to AEO as brands fight for visibility inside AI-generated answers.

Celebrating 11 years, the window treatment brand evolves into a global creative platform with influencer partnerships and a focus on community building.